Newsroom

We Build Drugs, Not Companies.™

VPD News & Events

PRESS RELEASES

January 4, 2018

Spitfire Pharma's SP-1373 outscored semaglutide and elafibranor in a biopsy-proven translational mouse model of non-alcoholic steatohepatitis (NASH)

May 24, 2016

Thunderbolt Pharma, Inc., a Vitesse Biologics Company, Acquires Rights to BAFF/APRIL Dual Antagonist Program from Astellas Pharma Inc.

June 1, 2015

Baxter Ventures, Mayo Clinic and Velocity Pharmaceutical Development announce the formation of Vitesse Biologics, LLC, a company structured to accelerate therapeutic innovation.

December 17, 2014

Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus

December 17, 2014

Tigercat Pharma, Inc. launches new website

September 8, 2014

Velocity Pharmaceutical Development CEO to Moderate Panel at BioPharm America 2014 Conference

August 4, 2014

Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce First Patient Dosed in Phase II Study of VPD-737 in Prurigo Nodularis

June 23, 2014

Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Regulatory Clearance for Initiating Phase II Study with VPD-737 in Prurigo Nodularis

August 19, 2013

Velocity Pharmaceutical Development and Tigercat Pharma Inc. Announce Submission of IND Application for VPD-737

August 19, 2013

Velocity Pharmaceutical Development and Remeditex Ventures Announce Collaboration Agreement and Initial
Co-Investment

January 15, 2013

Velocity Pharmaceutical Development Announces Clinical Development Agreement

EVENTS & PRESENTATIONS

June 15-18, 2015 | Philadelphia

VPD attending BIO International Convention

June 8-13, 2015 | Vancouver

VPD Attending 23rd Annual World Congress of Dermatology

March 20-24, 2015 | San Francisco

VPD attending American Academy of Dermatology Annual Meeting

January 12-15, 2015 | San Francisco

VPD attending JPM Healthcare Conference

January 11, 2015 | San Francisco

VPD and Tigercat Pharma, Inc. presenting at 2nd Annual Dermatology Summit

November 3-5, 2014 | Frankfurt

VPD Attending 20th Annual BIO-Europe International Partnering Conference

October 14, 2014 | Tokyo

VPD Presenting at Sofinnova Japan Biopharma Partnering Conference

October 7-8, 2014 | San Francisco

VPD Attending 13th Annual BIO Investor Forum

September 22-24, 2014 | Boston

VPD attending BioPharm America 2014 Conference

June 23-26, 2014 | San Diego

VPD attending BIO International Convention

June 13-17, 2014 | San Francisco

VPD attending American Diabetes Association - 74th Scientific Sessions

March 21-25, 2014 | Denver

VPD attending American Academy of Dermatology

January 7-10, 2014 | San Francisco

VPD attending JPM Healthcare Conference